Investor

Presentation

FY 2025 ResultsRainbow Global

Spain Manufacturing Base U.S. Houston Champaign

Manufacturing Base Weifang Qingdao Ningxia Manufacturing Bases

Manufacturing Bases

Subsidiary / Office

R&D Centers

Weifang Jinan R&D Centers

Weifang Process Development Center

Argentina Manufacturing Base

10100+130+

Factories Operational Overseas

Countries Subsidiaries

370+5100+≈8900

Independent Staffs Registrations

Patents Globally Globally2025 Crop Protection Industry Status

Improved supply- Industry recovery Strong overseas Some key markets

demand dynamics with leading demand recovery facing economic

prices stabilizing companies with stable challenges

at bottom rebounding first inelastic demand

1 2 3 4Industry Overview

Export Volume Trends of Products Under China HS Code 3808

10k Tons 2025 2024 2023 2022

35.00

30.8630.8630.2930.13

30.0028.62

27.4827.6426.93

27.2426.1725.47

24.8625.18

25.0024.0624.4824.9225.19

22.3322.9923.1122.54

22.21

22.99

20.70

21.83

20.0018.9021.3319.2518.5118.7519.75

17.4317.9918.7719.57

17.21

14.3914.43

17.1014.67

15.0014.4215.9615.41

11.9513.8213.21

12.83

10.0010.50

10k Tons 1 2 3 4 5 6 7 8 9 10 11 12

* FY 2025: Total export volume increased by 15.37% YoYIndustry Overview

Export Value Trends of Products Under China HS Code 3808

Hundred 2025 2024 2023 2022

Million

USD

12.00

11.0511.07

11.35

11.0010.47

10.009.86

9.029.10

9.008.808.798.84

8.18

8.007.887.697.657.857.67

7.447.647.717.797.287.71

7.006.317.266.657.506.756.926.66

6.946.32

7.157.276.81

6.65

6.006.586.586.075.425.536.126.415.905.82

5.005.604.945.41

4.59

4.00

3.00

2.00

Hundred 1 2 3 4 5 6 7 8 9 10 11 12

Million

USD

* FY 2025: Total export value increased by 13.14% YoYIndustry Overview

Export Unit Price Trends of Products Under China HS Code 3808

USD/Kg 2025 2024 2023 2022

7.00

5.976.00

6.005.655.855.58

5.355.325.485.31

4.93

5.004.574.56

4.134.174.41

4.003.883.59

2.983.173.043.153.143.26

3.273.07

3.002.872.792.812.922.97

3.043.033.013.003.083.05

2.872.852.923.022.962.922.962.862.672.692.752.85

2.00

1.00

-

123456789101112

USD/Kg

* FY 2025: Monthly average export unit price increased from $ 2.87/kg in January to $ 3.05/kg

in DecemberFY 2025 Operational Review

1. Global Management System: Building Long-Term Growth

Foundations

* Digital Integration & Data-Driven Operations: By end-2029 the company

aims to operate on a fully integrated global digital ecosystem—enabling

seamless collaboration real-time data visibility and advanced analytics to

support faster decision-making planning and scalable growth across all

markets.* Global Process Excellence: By end-2029 the company will standardize

and embed a set of core and supporting business processes across all

operations—creating a unified operating model that enhances efficiency

consistency and execution excellence worldwide. These processes are

designed to streamline decision-making improve cross-functional

alignment and ensure best practices are replicated at scale.FY 2025 Operational Review

2. Four Strategic Growth Pillars: Operation Review

2.1. Rising TO C 2.2. Significant 2.3. Continued 2.4. Rainbow Bio

Business Share and Progress in High-Value Optimization of Business

Profitability Market Expansion Product Mix Acceleration

TO C business revenue share Europe and North America Insecticide and fungicide revenue Rainbow Bio has launched

rose from 37.65% in 2024 to revenue share increased from revenue increased from 25.71% in operations in multiple countries

43.44% in 2025 with gross 9.75% in 2024 to 12.42%. 2024 to 30.15% reflecting a across Africa Asia and the

margin expanding from 28.99% Continued penetration in high- continued shift toward higher- Americas with the biologicals

to 31.68 % value markets value products segment emerging as a new

growth driverFY 2025 Operational Review

3. Market Risks

in Key Regions

Weighed on

Performance

Elevated debt default risks in key crop

protection markets particularly Brazil and

Argentina weighed on full-year performanceFY 2025 Operational Review

4. Enhance Quality 4.1 Identifying Capability Gaps Strengthening Strategic ExecutionBoost Efficiency:

Global Marketing The company's 2025-2029 mid-term strategic plan identifies two key capability gaps on the market front line: commercializing differentiated products successfully and

brand business building capability.Network Expansion In response the market front line quickly realigned its focus driving key initiatives

and Optimization around these two core capabilities. The team demonstrated strong strategic alignment and execution ensuring effective implementation of corporate strategy.

4.2 Proactive Realignment of Performance Metrics

Significantly Improved Operational Quality

The company promptly recalibrated organizational performance targets. By

significantly increasing weightings for operational quality indicators (gross margin

rate NPAT overdue AR and long-term inventory) while drastically reducing the

weighting for sales revenue it effectively guided business behavior. Currently

operational quality is steadily improving with growing resilience.FY 2025 Operational Review

4. Enhance Quality 4.3 Talent Strategy and Corporate Culture ConfidenceBoost Efficiency: We maintain a policy of deploying Chinese core staff overseas to ensure strategic alignment and cultural integration. Meanwhile we dynamically optimize key roles at

Global Marketing overseas subsidiaries including local general managers. After replacing underperforming Model C subsidiary general managers in 2024-2025 the affected

subsidiaries saw significant performance improvement.Network Expansion Currently most Model C subsidiaries operate under a "Commissar + Commander"

and Optimization model (veteran Chinese expats paired with local leaders). This model significantly enhancing the company's cultural confidence in global operations.

4.4 Model C Subsidiary Delivers Stronger Operational

Performance

The company's Model C subsidiaries have steady performance improvement over the

past five years delivering strong and sustainable results as the global operations

system matures.FY 2025 Operational Review

4. Enhance Quality 4.5 Stronger Registration FootprintBoost Efficiency: Through forward-looking product planning the company identifies key products including relatively new active ingredients and important differentiated formulations

Global Marketing and leads global registration and commercial planning.In 2025 the company secured approximately 1200 new registrations reaching

Network Expansion approximately 8900 total global registrations as of December 31 2025 laying a solid

foundation for early commercialization in core and key markets.and OptimizationFY 2025 Operational Review

5.1 Active Ingredient Synthesis Projects on Track

Strengthening Advanced Manufacturing Foundation

The company firmly executed its active ingredient manufacturing plan targeting an

average of at least two new active ingredient synthesis projects commenced per year

during the 2025-2029 strategic period. In 2025 the plan was delivered efficiently:

technical upgrades and capacity expansion of existing projects such as Clethodim

and Propanil strengthened product cost and quality advantages while two new

projects—Pyroxasulfone and Bicyclopyrone—were successfully completed and put

5. into operation.5.2 Forward-Looking Formulation Capacity Ensures

R&D-Driven Advanced Fast High-Quality Delivery

Manufacturing: Rapid To ensure high-quality low-cost fast and on-time delivery of global orders the company

proactively built formulation capacity in line with its strategic plan. In 2025 two new workshops

High-Quality Progress per were completed and put into operation: the solid formulation workshop for insecticides and fungicides and the SC (suspension concentrate) workshop.Strategic Plan These new workshops achieved significant improvements in continuous production automation

and intelligence optimizing production processes and enhancing both efficiency and product

consistency. This provides strong capacity support for high-quality fast delivery to global

markets.FY 2025 Operational Review

5.3 Strengthening Formulation Tech to Enable

Lean Production

The company has built highly adaptable and efficiently coordinated formulation technology

capabilities. In 2025 multiple new formulation types including OD SE CS and ZC achieved

industrial-scale production with key technical bottlenecks overcome. Product adaptability

and stability across different crops and regional scenarios improved significantly. Meanwhile

integrated smart manufacturing technologies were applied across formulation production

lines with automated and digital equipment deeply enabling lean production. Technology

5. advantages are rapidly translating into market competitiveness.

R&D-Driven Advanced 5.4 Precision Product Selection and Forward Planning to Seize Market Opportunities

Manufacturing: Rapid

Based on a thorough understanding of the entire industrial chain the company has established a

High-Quality Progress per scientific product selection and planning system. It has evaluated all key active ingredients set to go off-patent by the end of 2035 and selected approximately 30 relatively new active ingredients

Strategic Plan with significant market potential. For these active ingredients the company has initiated forward-looking global registration market and R&D planning aiming to become an advanced

manufacturer of these relatively new active ingredients and in each key target market to be the

first generic entrant after the originator. This strategy will secure the company a favorable

competitive position in future markets and enable differentiated growth.Financial Highlights

FY 2025 Financial Performance Analysis (YoY)

Currency

RMB 2025 2024 % ▲ Note

Sales Revenue 14688354045.60 13296203422.72 10.47% Recovery in overseas demand and stable inelastic demand

Driven by a higher TO C business share

Gross Margin（%） 22.80% 19.79% 301bps and YoY gross margin improvement

across all business models

EBITDA 1943263061.15 1310196303.64 48.32% Revenue and gross margin rate both up

EBITDA Profit（%） 13.23% 9.85% 338bps Gross margin rate significantly up

Net Profit Attributable to the

Owner of Parent 1044521901.70 450082509.47 132.07% Revenue and gross margin rate both up

Net Operating Cash Flow 2143365422.14 751338988.37 185.27% Improved payment collection

2025: Net Profit Attributable to the Owner of Parent at RMB 1.045 billion. Exchange rate-driven forex and hedging losses reduced profit by RMB 0.97 million. Excluding this adjusted net profit at RMB 1.045 billion;

2024: Net Profit Attributable to the Owner of Parent at RMB 450 million. Exchange rate-driven forex and hedging losses reduced profit by RMB 440 million. Excluding this adjusted net profit at RMB 890 millionFinancial Highlights

FY 2025 Financial Performance Analysis (YoY)

Currency

RMB 2025 2024 % ▲ Note

Higher sales expenses mainly

Selling & Distribution stemmed from increased overseas

Expenses 736069496.31 654095305.31 12.53% payroll export credit insurance and

Advertising expenses

Mainly due to increased overseas

General & Administrative

Expenses 585508389.57 547396454.50 6.96% payroll travel expenses and IT

costs

R&D Expenses 8.22% Primarily due to increased R&D 183340065.45 169415449.97 staffFinancial Highlights

FY 2025 Revenue Status by Region

FY 2025 Revenue：

14.688 billion RMB

Brazil North Oceania Middle Latin Asia (China2025 31.95% America 5.84% East/Africa America Europe inclusive)8.02% 9.17% 24.16% 7.53% 13.33%

2024 Brazil North Oceania Middle Latin Europe Asia (China28.34% America 8.47% East/Africa America 7.36% inclusive)5.71% 8.71% 28.49% 12.92%Financial Highlights

EBITDA% by Quarter

EBITDA%

16.00%

13.99%14.13%

14.00%13.57%13.23%

12.79%12.53%

11.80%

12.00%

10.33%

10.00%9.85%

8.00%

6.00%

4.00%

2.73%

2.00%

0.00%

Q1 Q2 Q3 Q4 Total

2024 2025Financial Highlights

Revenue Share by Business Model (YoY)

Annual Revenue by Business Model

Mode C Mode C

37.65%43.44%

Mode A + Mode A +

Mode B Mode B

62.35%56.56%

2024 2025Financial Highlights

Gross Margin Rate Comparison by Business Model

Annual Gross Margin Rate by Business Model

35.00%

31.68%

30.00%28.99%

25.00%

20.00%

15.98%

15.00%14.23%

10.00%

5.00%

0.00%

Mode A + Mode B Mode C

2024 2025Financial Highlights

Revenue by Product Category

Annual Revenue by Product Category

Other Other

1.10%1.68%

Fungicide Fungicide

9.88%10.72%

Insecticide

15.83% Insecticide

19.43%

Herbicide Herbicide

73.19%68.17%

2024 2025Financial Highlights

Gross Margin Rate Comparison by Product Category

Annual Gross Margin Rate by Product Category

30.00%28.57%

26.91%

26.32%

25.00%

22.05%

20.33%

20.00%

17.76%

15.00%

10.00%

5.00%

0.00%

Herbicide Insecticide Fungicide

2024 20252026 Global Crop Protection

Industry Outlook

Geopolitical Conflicts Drive

Market Volatility and Industry Recovery with Supply Chain Resilience as Generic Crop Protection

Uncertainty Clear Leader Advantage a Key Competitive Factor Gaining Market Share Faster

The US-Iran conflict in February 2026 The global crop protection industry Amid rising geopolitical tensions Prices of most crop protection

disrupted global energy markets and is expected to continue recovering. and trade protectionism active active ingredients have continued

the chemical industry chain driving As channel inventory normalizes ingredients may experience sharp to decline over the past few years

rapid price increases for most active downstream procurement demand short-term volatility due to highlighting the cost advantage of

ingredients. Further developments should gradually recover. The unforeseen events. Precise generic products. As commodity

will continue to add significant cyclical bottom recovery is more inventory management agile prices soften growers seeking to

uncertainty to the global crop evident for leading companies with market strategies and rapid improve returns will increasingly

protection market in 2026 competitive advantages. Top-tier response capabilities have favor cost-effective generic

players with core technology therefore become key to products accelerating their market

innovation capabilities and global navigating market changes and share growth

channel brands will further maintaining competitiveness.consolidate their market position

1 2 3 42026 Business Outlook

Margin Expansion

Geopolitical Risks Trade Protectionism Continued Industry Challenges Recovery Driven by Business Mix

Optimization

The US-Iran conflict in February Rising trade protectionism in Global agrochemical industry sentiment Increased TO C Business and

2026 triggered sharp volatility in multiple countries has is expected to continue recovering. As high-value product registrations in

global energy markets significantly disrupted import channel inventory gradually normalizes key markets will continue to drive

significantly impacting the tariffs market access policies downstream procurement demand is up the company's overall gross

chemical industry chain. Although exchange rates and commodity expected to further recover while end- margin rate

the situation has recently eased prices in affected countries market prices and gross margins are

geopolitical risks remain. Further adding some uncertainty to the set to gradually return to rational levels.developments could continue to company's operations Gross margins for most subsidiaries in

affect energy prices and raw target countries are expected to

material supply creating continue rising

uncertainty for the company's

operations

1 2 3 42026 Business Outlook

Advanced Manufacturing Continued Operational Quality

Drives Growth Improvement 2026 Performance Targets

R&D-driven advanced manufacturing Leveraging a global management system Based on the company's 2026 operational

capabilities continue to advance helping supported by processes and IT systems the targets revenue gross margin rate EBITDA and

the company increase global market share company's global operations capabilities have net profit attributable to the owner of parent are

and improve gross margin rate continued to improve with operational quality all expected to trend upward YoY

expected to keep improving

5 6 7Mid-Term Strategic Plan (2025-2029)

"Enhance Quality Boost Efficiency"Mid-Term Strategic Plan (2025-2029)

4 Strategic Growth Pillars

1 Increased To C Business

2 Increased Europe & North American Business

3 Increased Insecticide & Fungicide Business

4 Rainbow Bio Business AccelerationMid-Term Strategic Plan (2025-2029)

7 Critical Tasks

1. Building up the global management system to ensure the company under healthy and safe operation

2. Identifying important products prospectively be the first generic company to commercialize in core markets successfully

3. Identifying suitable AI ensure the successful implementation through strong and advanced technology with proper ways so that we can have more global powerful synthesis AI to support our market development improving our competitivity and profitability.

4. Improving the formulation capabilities to be high cost-effective and efficient to support product registration quick delivery andsuccessful commercialization

5. Continue expanding and developing global business strengthen brand building to ensure business grow in a balanced and healthy way

6. Thoroughly understand the information from factories to farms making accurate and quick decisions developing more niche AIs andbuilding strategy aligns partners with different ways to ensure global supply chain to be safe and competitive

7. Continuously optimizing orders’ whole processing system to ensure the high-quality cost-effective and fast delivery on scheduleMid-Term Strategic Plan (2025-2029)

5 Key Management Capabilities

1 Global Management System

2 To commercialize differentiated products successfully

3 High cost-effectiveness efficient and coordinate differentiated formulation vtechnologies

4 Brand Business Building Capability

5 Efficient Agile and Accurate Decision-Making Supply ChainTo be a Global Leading Crop

Protection Company

THANK YOU